On February 2, 2022 Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, reported that it has been selected as one of FORTUNE’s World’s Most Admired Companies in 2022 for the eighth consecutive year (Press release, Quest Diagnostics, FEB 2, 2022, View Source [SID1234607664]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Fortune’s World’s Most Admired Companies recognition is based on nine criteria of corporate reputation, from investment value and quality of management and products, to social responsibility and ability to attract talent.
The annual survey designated Quest as one of only six companies to attain Most Admired status in the "Health Care: Pharmacy and Other Services" industry. The company scored high marks in use of corporate assets, quality of management, and social responsibility.
"It is an honor to be named one of Fortune World’s Most Admired Companies for the eighth year in a row," said Steve Rusckowski, chairman, chief executive officer and president of Quest Diagnostics. "This recognition is truly a testament to the deep commitment and passion of our 50,000 employees working to create a healthier world every day."
To determine the rankings, Fortune partnered with global organizational consulting firm Korn Ferry to survey thousands of executives, directors and analysts who rated companies in their industry on nine criteria, including investment value and quality of management and products to social responsibility and ability to attract talent. The survey included a total of 640 companies from 28 countries. A company’s score must rank in the top half of its industry survey to be listed as a World’s Most Admired Company.